Permeation Enhancement

The Biopharmaceutics Classification System (BCS) classifies active pharmaceutical ingredients (API's) based on the solubility and permeability of each respective API. API's that are BCS Class III & IV are poorly permeable, indicating that they will exhibit reduced bioavailability due to reduced transit across the GI tract. Formulating these API's in a lipid based drug delivery system can enhance the permeability of these molecules and ensure improved bioavailability.

CAPMUL® - Where Formulation Begins™

ABITEC has expanded its portfolio of CAPMUL bioavailability enhancers which are medium-chain mono- and di-glycerides and propylene glycol esters. These functional lipid excipients act as solubilizers and emulsifiers in oral, topical, transdermal, and parenteral drug delivery systems. CAPMUL excipients are recognized as the ideal starting point when formulating BCS Class II & IV (poorly water soluble) and BCS Class III & IV (poorly permeable) molecules. Lipid based drug delivery systems may be formulated as liquid or semi-solid formulations for oral dosage and can also be employed as solubilizers, emulsifiers, and penetration enhancers in creams and ointments for both topical and transdermal applications.

Functionalities Include:

  • Bioavailability enhancer
  • Solubilizer
  • Emulsifier/co-emulsifier
  • Carrier (vehicle)
  • Employment through SEDDS - self emulsifying drug delivery systems

Specifically for Permeation Enhancement:

  • Major advantages in the areas of drug solubility and protection against enzymatic hydrolysis, coupled with enhanced absorption.
  • Efficient in the solubilization or dispersion of active substances and polar lipids.
  • Effective in self-emulsifying drug delivery systems (SEDDS) when incorporated as a low HLB water-in-oil (w/o) emulsifier or co-emulsifier.
  • Useful enhancer for intestinal absorption of poorly absorbed drugs due to Capmul's low acute oral toxicity and its absence of local irritation.
  • Potential to enhance the release and availability of many drugs that are impermeable to tissue barriers and poorly absorbed due to either low partition coefficient or low diffusibility.

Available Products:

Product Name Chemical Name CAS Number
Capmul 808G EP/NF Glyceryl Monocaprylate 26402-26-6
Capmul MCM C8 EP/NF Glyceryl Monocaprylate 26402-26-6
Capmul MCM NF Glyceryl Caprylate/Caprate 91744-32-0,
Capmul MCM EP/NF  Glyceryl Caprylate/Caprate  91744-32-0,
Capmul PG-8 NF Propylene Glycol Monocaprylate 68332-79-6
Capmul PG-12 EP/NF Propylene Glycol Monolaurate 27194-74-7

Visit our Resource Center

Legal Disclaimer

CAPMUL® is a registered trademark of ABITEC Corporation.   All information and statements given on this website are believed to be accurate at the time of publication. However, neither ABITEC Corporation nor any of their affiliates make any representations or warranty with respect thereto, including, but not limited to, any results obtained in the processing of the products by customers or any third party. All information and statements are intended for persons having the required skill and know-how and do not relieve the customer or user from verifying the suitability of information and statements given for a specific purpose prior to use of the products. It is entirely the obligation of the customer or user to comply with applicable laws and regulations, and also with all patent or other intellectual property rights of third parties. ABITEC CORPORATION EXPRESSELY DISCLAIMS ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND, WHETHER EXPRESSED OR IMPLIED, AS TO THE ACCURACY, CURRENCY, COMPLETENESS AND/OR THE MERCHANTABILITY OR FITNESS OF A PARTICULAR PURPOSE OF ANY INFORMATION CONTAINED ON THIS WEBSITE AND/OR PRODUCT DESCRIBED OR PROMOTED ON THIS WEBSITE, INCLUDING WARRANTIES WITH RESPECT TO INFRINGEMENT OF ANY PATENT, COPYRIGHT, OR OTHER RIGHTS OF A THIRD PARTY. We reserve the right to change product specifications and specified properties of the products without prior notice.